Live Breaking News & Updates on Arun kedia

Stay informed with the latest breaking news from Arun kedia on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Arun kedia and stay connected to the pulse of your community

VAV Lipids forays into Latin American market - The Hindu BusinessLine

VAV Lipids forays into Latin American market - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Peru , Brazil , United-states , Mexico , Mumbai , Maharashtra , India , Argentina , Colombia , America , American , Arun-kedia

No turning back on the biotech super highway - The Hindu BusinessLine

No turning back on the biotech super highway - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

India , Japan , Telangana , Andhra-pradesh , Bengaluru , Karnataka , Hyderabad , Japanese , Sudarshan-jain , Jitendra-kumar , Arun-kedia , Indian-pharmaceutical-alliance

VAV Lipids earns appreciation from U.S. Pharmacopeia

Mumbai (Maharashtra) [India], March 1 (ANI/NewsVoir): VAV Lipids has announced that it received a Certificate of Appreciation from United States Pharmacopeia (USP) for its contribution to the standards-setting activities in lipid manufacturing. United States Pharmacopeia (USP) recognized the efforts of VAV Lipids Private Limited in providing candidate documentary and reference standards that reached important milestones in 2022. It awarded a Certificate of Appreciation to the company in acknowledgment of the outstanding contribution that it made toward global public health through the advancement of USP standards. Speaking of the development, Arun Kedia, Managing Director, VAV Lipids said, "We are deeply honoured and humbled at the recognition bestowed on us. We are grateful to USP for inviting us to contribute to the standard-setting process and making us a part of their mission to improve global health through public standards." USP's Certificate of Appreciation noted that VAV Lipids' contributions have added significant public benefit to the standards-setting process in support of the USP mission, that is, to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. VAV Lipids is one of the world's leading manufacturers of specialized phospholipids for novel drugs and biologics delivery systems (NDDS). Its high-quality lipids are used by pharmaceutical companies to develop multiple projects in drugs and biologics delivery. These include applications of lipids in developing vaccines and formulations, cancer therapy based on liposomes, and novel drug delivery systems for treating several diseases. The company is based in India. VAV Lipids, a subsidiary of VAV Life Sciences is a research-driven biopharmaceuticals manufacturing company headquartered in Mumbai, India. The company produces high-grade ingredients used in the pharmaceutical, nutraceutical, healthcare & personal care industries. It is among the world's leading manufacturers of phospholipids and lecithin. The company has a state-of-the-art EU cGMP-certified facility for manufacturing phospholipids at Ratnagiri in Maharashtra. VAV's product portfolio includes plant phospholipids (LECIVA), Animal phospholipids (LIPOVA), synthetic phospholipids, and neutral lipids. The other products include APIs and specialty proteins. VAV exports almost 80% of its products primarily to North America, Europe, and Asia. VAV Lifesciences is also working in close cooperation with reputed academic research institutions for the development of advanced and novel drug delivery therapies. This story has been provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

Ratnagiri , Orissa , India , Mumbai , Maharashtra , United-states , America , Arun-kedia , Lipids-private , Life-sciences , United-states-pharmacopeia , States-pharmacopeia

VAV Lipids earns appreciation from U.S. Pharmacopeia

Mumbai (Maharashtra) [India], March 1 (ANI/NewsVoir): VAV Lipids has announced that it received a Certificate of Appreciation from United States Pharmacopeia (USP) for its contribution to the standards-setting activities in lipid manufacturing.

United-states , Mumbai , Maharashtra , India , Ratnagiri , Orissa , America , Arun-kedia , Lipids-private , Life-sciences , United-states-pharmacopeia , States-pharmacopeia

VAV's Lipid Solutions for Advanced Vaccines and Formulations Sparks Global Interest

Mumbai (Maharashtra) [India], November 29 (ANI/NewsVoir): VAV Lipids, one of the world's leading manufacturers of specialized phospholipids for novel drugs and biologics delivery systems (NDDS) reported successful outcomes at the CPHI 2022, the world's largest pharmaceutical and bio exhibition, held in Frankfurt, Germany. During the event which was held for three days from November 1 to 3, VAV Lipids showcased its lipid product range to global pharmaceutical and vaccine producers attending the event. VAV's high-quality lipids attracted significant attention for their potential to help pharmaceutical companies to develop multiple projects in drugs and biologics delivery. These included applications of lipids in developing thermostable vaccines and formulations, cancer therapy based on liposomes, and treatment of chronic autoimmune and neuromuscular diseases like myasthenia gravis and multiple sclerosis. There was specific interest in new upcoming technologies based on lipids, especially in the development of antibodies, RNA, oligonucleotides, and several advanced medical products. There was also interest in VAV's lipids for developing animal vaccines and aquaculture. The applications of lipids in reformulating generic drugs to make them more efficient also received significant attention from global generic pharmaceutical companies. Speaking of the overwhelming response at the exhibition, Arun Kedia, Managing Director, VAV Lipids, said, "This highlights the disruptive potential of lipid nanotechnology in healthcare. Our technology helps address untreatable disease segments and will indeed offer hope to patients suffering from these diseases. We are looking to partner with various major healthcare companies in our quest to make healthcare delivery better." During the event, the company met with several top-ranking officials from some of the top pharmaceutical, nutraceutical, and healthcare companies of the world. Discussions were held with global multinationals for possible strategic partnerships, based on VAV's significantly enhanced manufacturing capabilities to supply lipids to exacting global standards. VAV Lipids, a subsidiary of VAV Life Sciences is a research-driven biopharmaceuticals manufacturing company headquartered in Mumbai. The company produces high-grade ingredients used in the pharmaceutical, nutraceutical, healthcare & personal care industries. It is among the world's leading manufacturers of phospholipids and lecithin. The company has a state-of-the-art EU cGMP-certified facility for manufacturing phospholipids at Ratnagiri in Maharashtra. VAV's product portfolio includes plant phospholipids (LECIVA), Animal phospholipids (LIPOVA), synthetic phospholipids, and neutral lipids. The other products include APIs and specialty proteins. VAV exports almost 80% of its products primarily to North America, Europe, and Asia. VAV Life Sciences is also working in close cooperation with reputed academic research institutions for the development of advanced and novel drug delivery therapies. This story has been provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

Germany , United-states , Mumbai , Maharashtra , India , Ratnagiri , Orissa , America , Arun-kedia , Life-sciences , Managing-director , North-america

VAV Lipids: VAV to Strengthen Its Presence in Spain with COSMOS-certified Cosmetics Ingredients

VAV Lipids, a biopharmaceuticals manufacturing company, headquartered in Mumbai, India has announced it will strengthen its presence by continuing to build a pipeline of COSMOS-certified ingredients

Mumbai , Maharashtra , India , Spain , Aloma-carvalho , Kostenloser-wertpapierhandel , Arun-kedia , Managing-director , Lipids , Trengthen , Resence

VAV Life Sciences' Ingredients Receive COSMOS Approval

“This is certainly a step forward for VAV as we always aim to meet the highest standards possible in manufacturing sustainable products,” said Arun Kedia, managing director of VAV Life Sciences.

Arun-kedia , Life-sciences , Vav-life-sciences ,

The league of little-known companies that stepped up to make Covid-19 drugs and vaccines

The league of little-known companies that stepped up to make Covid-19 drugs and vaccines
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

China , Japan , India , Ratnagiri , Orissa , Russia , Kerala , Tamil-nadu , Sun-pharma , Dharwad-karnataka , Arun-kedia , Jyothi-datta

VAV Life Sciences ramps up production of lipid ingredients for Liposomal Amphotericin B

Liposomal Amphotericin B is the drug used for treating mucormycosis

Mumbai , Maharashtra , India , Ratnagiri , Orissa , Arun-kedia , Life-sciences , Black-fungus , Liposomal-amphotericin , Liposomal-amphotericin-b , Av-life-sciences , மும்பை

How VAV Life is stepping up supplies of key inputs for vaccines, black fungus drug

How VAV Life is stepping up supplies of key inputs for vaccines, black fungus drug
May 25, 2021
The company supplies synthetic phospholipids to a US-based firm that supplies Pfizer and Moderna for their mRNA vaccines
The company supplies synthetic phospholipids to a US-based firm that supplies Pfizer and Moderna for their mRNA vaccines×
The order book of VAV Life Sciences was full and its production facility in Ratnagiri was already running three shifts. But it just got busier for the Mumbai-based biopharmaceutical company, following the widespread emergence of ‘black fungus’ across the country. VAV makes the crucial lipid ingredient needed for Liposomal Amphotericin B, used to treat the fungal infection.

Germany , Mumbai , Maharashtra , India , Ratnagiri , Orissa , Arun-kedia , Pfizer , Life-sciences , Managing-director , Covid-vaccines , Mrna-vaccines